PE is negative at -42
THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED
Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane
Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years
Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition
mutual funds have increased stake from 0.25% to 1%
DII also increasing stake significantly
stock has come out of accumulation Phase!!!
THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED
Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane
Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years
Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition
mutual funds have increased stake from 0.25% to 1%
DII also increasing stake significantly
stock has come out of accumulation Phase!!!
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.